Do you want to read an article? Please log in or register.
A predictive model based on quantitative fecal immunochemical test can stratify the risk of CRC in an organized screening program
ColonoscopyGastrointestinal Cancer
Related content
Gastrointestinal Cancer
Yield and Effectiveness of Two-Sample Fecal Immunochemical Test-based Screening Program for Colorectal Cancer
Clin Gastroenterol Hepatol
Xu Z, Yang J, He J, Li Q, Fei X, Bai H, Gao K, He Y, Li C, Tang M, Wang J, Jin M, Chen K
doi: 10.1016/j.cgh.2024.10.010
Gastrointestinal CancerFurther Publications
Harm-to-benefit ratio of fecal immunochemical test-based screening for colorectal cancer given prior fecal hemoglobin concentrations
Clin Gastroenterol Hepatol
Toes-Zoutendijk E, van de Schootbrugge-Vandermeer HJ, Katsara MA, de Jonge L, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Dekker E, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I, Meester RGS
doi: 10.1016/j.cgh.2024.08.041
Colonoscopy
Colorectal cancer incidence following a negative colonoscopy in fecal immunochemical test-based screening: a nationwide cohort study after 8 years of screening in Denmark
Endoscopy
Larsen PT, Jørgensen SF, Rasmussen M, Andersen B, Cross AJ, Njor SH
doi: 10.1055/a-2551-1471
ColonoscopyGastrointestinal Cancer
CT-colonography in Fecal Immunochemical Test Positives in a Colorectal Cancer Screening Program
Clin Gastroenterol Hepatol
Moen S, Marijnissen FE, Terhaar Sive Droste JS, de Vos Tot Nederveen Cappel WH, Spanier BWM, Huisman JF, Dekker E, Stoker J, Kuipers EJ, Thomeer MGJ, Spaander MCW, CT in BVO Study Group, Wolters LMM, Leeuwenburgh I, Tielemans MM, Vos XG, van Kouwen MCA, Kerkhof M, Schrauwen RWM, Veenstra RP, Capelle LG, Bigirwamungu-Bargeman M, Wientjes CA, van Enckevort C, Mulder SA, Cahen DL, Seerden TC, Gilissen LPL, Eichhorn R, Bus P, de Ridder RJJ, Buster EHCJ, van Nunen AB
doi: 10.1016/j.cgh.2025.03.009
Gastrointestinal CancerFurther Publications
Participation and Yield in Multiple Rounds of Colorectal Cancer Screening based on Fecal Immunochemical Test: A Systematic Review and Meta-Analysis
Am J Gastroenterol
Zhou Y, Li N, Luo J, Chen Y, Zhang Y, Dai M, Chen H
doi: 10.14309/ajg.0000000000003107
Gastrointestinal Cancer
Reliable Performance of mALBI Grade-Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First-Line Treatment: Comparative Analysis of 13 Risk Models
J Gastroenterol Hepatol
Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Toyoda H, Ogawa C, Nishikawa H, Nishimura T, Kawata K, Kosaka H, Naganuma A, Yata Y, Ohama H, Kuroda H, Matono T, Tanaka K, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Kumada T, Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
doi: 10.1111/jgh.16871
COMMENTED
ColonoscopyGastrointestinal Cancer
Colorectal cancer screening based on predicted risk: a randomized controlled trial
★ 2
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Plys E, Bulliard JL, Chaouch A, Durand MA, van Duuren LA, Braendle K, Auer R, Froehlich F, Vogelaar IL, Corley DA, Selby K
doi: 10.14309/ajg.0000000000003311
Hepatology
Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study
Am J Gastroenterol
Caviglia GP, Ferro A, D'Ambrosio R, Perbellini R, Lampertico P, Periti G, Valenti L, Ciccioli C, Pennisi G, Petta S, Brodosi L, Petroni ML, Marchignoli F, Pironi L, Sagripanti A, Argenziano ME, Svegliati-Baroni G, Rosso C, Barutta F, Armandi A, Gruden G, Bugianesi E
doi: 10.14309/ajg.0000000000003493
ColonoscopyGastrointestinal Cancer
Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial
Lancet
Castells A, Quintero E, Bujanda L, Castán-Cameo S, Cubiella J, Díaz-Tasende J, Lanas Á, Ono A, Serra-Burriel M, Frías-Arrocha E, Hernández C, Jover R, Andreu M, Carballo F, Morillas JD, Salas D, Almazán R, Alonso-Abreu I, Banales JM, Hernández V, Portillo I, Vanaclocha-Espí M, de la Vega M, COLONPREV study investigators
doi: 10.1016/S0140-6736(25)00145-X